In our work, we describe a double action of propranolol in the tumour microenvironment by inhibiting the stability of HIF1α and thus mediating decrease of CA IX expression and, at the same time, by its effect on CA IX activity by decreasing the activity of PKA and consequences on proliferation and migration of tumour cell in 3D model of spheroids. The gene discussed is CA9; the disease is neoplasm.